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1. Introduction 
The concepts of 'nano-technology' was introduced by the physicist Richard Feynman in his 
talk "There's Plenty of Room at the Bottom"  at an American Physical Society meeting at 
Caltech on December 29, 1959. Feynman described a process by which individual atoms and 
molecules might be manipulate, using a set of precise tools to build and operate another 
smaller scale set of tools, scaling down to the nano-scale. In the course of this, he noted, 
scaling issues would arise from the changing magnitude of various physical phenomena: 
gravity would become less important, surface tension and Van Der Waals attraction would 
become increasingly more significant, etc. The term "nanotechnology" was defined by 
Professor Norio Taniguchi of Tokyo Science University in a 1974 paper in which he states 
"'Nano-technology' mainly consists of the processing of, separation, consolidation, and 
deformation of materials by one atom or by one molecule." Almost four decades later, 
nanotechnology has had an impact on all sectors of human life including electronics, 
computers and mobile phones; food and agriculture industries; composite materials, textiles, 
paints and cosmetics; and, of course, healthcare. In today’s market there are thousands of 
products based on nanotechnology, produced by hundreds of companies worldwide. 
Essentially, nanotechnology entails the manufacturing and manipulation of matter at a scale 
ranging from a single atom to micron-sized objects. In biology, nanomaterials are a 
comparable size to many biological functional molecules such as proteins and are often 
small enough to fit inside a cell. Being at the same microscopic scale as biological functions 
allow nanoparticles to interact with many biological processes, this potentially can have an 
impact in many aspects of the healthcare. The new field of ‘Nanomedicine’ (Allhoff, 2009) 
will not meets its immense potential until the safety of nanomaterials is fully demonstrated. 
It is prudent to investigate any potential adverse effects on health or the environment of 
nanomaterials. However with suitable safe guards and internationally agreed standards 
emanating from these nano-safety and toxicity studies, there seems little reason to doubt the 
overriding benefit that nanomedicines will provide in the 21st Century (Jain et al., 2008). 
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Nanomedicine has been defined as the application of nanotechnology in healthcare. Their 
size and shape confers them with unique electrical, thermal, optical and magnetic properties 
(Emerich et al., 2007). They have large surface area to volume ratio and if chemically 
modified increases their application. In principle, it is possible to fabricate nanoparticles that 
can be used in the early detection and prevention of diseases, to improve diagnosis, 
treatment and follow-up. It has already enabled miniaturization of many current devices 
resulting in faster operation or enhanced integration of several operations. There are many 
biomedical nanoparticles on the market, with different physical and chemical properties. In 
the following discussion we will be investigating the potential use of carbon nanotubes in 
biomedical applications. This will include safety issue, and an overview of the current and 
the future perspectives of the exploitation of their magnetic properties for imaging and 
therapies.  
2. Carbon nanotubes 
Carbon nanotubes are either single-wall (SWCNTs) consisting of a single graphite lattice 
rolled into a perfect cylinder or multi-wall (MWCNTs) made up of several concentric 
cylindrical graphite shells (Russian doll configuration). CNTs are usually produced by 
catalytic chemical vapour deposition and contain metals, mainly Fe at their closed ends 
(Kim et al., 2005). For this reason they are paramagnetic – a valuable property for certain 
biomedical applications. CNTs vary in diameter (from a few nm to 100 nm) and widely in 
length (up to several mm). Their molecular structure accounts for their unique properties: 
high tensile strength, high electrical conductivity, heat resistance and efficient thermal 
conduction and relative chemical inactivity (constituent atoms not easily displaced). The 
exact structure of CNT especially their n – m chirality determines their electric properties. 
When n-m is a multiple of 3 (armchair type), the CNTs have static dielectric properties, i.e. 
exhibit a metallic longitudinal and an insulator transverse response. In practice all 
multiwalled CNTs behave in this way. By virtue of their nano-scale, electron transport in 
CNTs occurs through quantum effects and thus only propagates uni-dimensionally along 
the axis of the tube. One of the problems which have impeded the use of CNTs for 
biomedical applications which has since been resolved is their insolubility in aqueous 
solution. This is an essential requirement for biological interactions and biocompatibility. 
Coating their surface with covalent and non-covalent polymer improves their solubility, 
enabling in-vitro cell viability assays and in-vivo studies on biocompatibility (Kagan et al., 
2010; Dutta et al., 2007). Carbon nanotubes will interact with cells and their ‘needle-like’ 
shape helps them cross cell membranes. By virtue of this characteristic, they can be used as 
carriers for drug and DNA delivery. Several groups have demonstrated that both SWCNTs 
and MWCNTs can be internalized by a variety of cell types with no external agent required 
facilitating the delivery of therapeutic and diagnostic small molecules (Kostarelos et al., 
2007; Shi Kam et al., 2005). 
2.1 Open issue: CNTs toxicity 
In recent years, conflicting data have been reported concerning safety and biocompatibility 
of these nanotubes. In a study on the cytotoxicity of unrefined SWCNT to immortalized 
human epidermal keratinocytes (HaCaT), Shvedova et al showed accelerated oxidative 
stress, loss in cell viability and morphological alterations of cellular structures. They 
concluded that those effects were the result of high concentration of residual iron catalyst 
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(30%) present in the unrefined SWCNTs (Shvedova et al, 2003). Other groups confirmed 
these toxic effects, e.g., induction of intracellular reactive oxygen species (ROS) (Pulskamp et 
al., 2007), DNA damage (Zhu et al., 2007) and cell apoptosis (Bottini et al., 2007). Recently, 
Poland et al demonstrated that exposure of the mesothelial lining of the peritoneal cavity of 
mice to long (10-15mm) multi-walled carbon nanotubes results in asbestos-like, length-
dependent, pathological inflammation and the formation of giant cell granulomas (Poland et 
al., 2008). In sharp contrast, other reports have demonstrated that CNTs do not induce toxic 
effects on cells. Huczko et al showed that CNTs exhibited negligible risk of skin irritation 
and allergy (Huczko et al., 2001). Cherukuri et al observed that macrophages phagocytosed 
SWCNTs at the rate of approximately one SWCNT per second without any apparent 
cytotoxicity (Cherukuri et al, 2004). Kam et al reported no cytotoxicity for the pristine 
SWCNTs and Pantarotto et al concluded that CNTs coated DNA provided a useful vector 
for safe gene delivery (Shi Kam et al., 2004; Pantarotto et al., 2004). 
The exact fate of carbon nanotubes inside the cells and in animals remains controversial. In 
vitro studies showed that SWCNTs can be degraded by living cells which cause their 
complete biodegradation (Kagan et al., 2010); however the degradation of MWCNTs  has 
not been demonstrated. Only a few studies have been published on the bio-distribution of 
carbon nanotubes in vivo. Singh et al. studied CNT bio-distribution following 
intraperitoneal administration in mice and they observed rapid blood clearance from 
systemic blood circulation through renal excretion. Moreover, urinary excretion studies 
using both f-SWNT and functionalized MWCNT followed by electron microscopy analysis 
of urine samples revealed that nanotubes were excreted as intact nanotubes after three 
hours (Singh et al., 2006). More work is needed to understand the clearance of nanotubes 
and more fully characterise what influences their biodistribution, degradation and 
excretation. A major source of toxicity is the presence of impurities, so it is important that 
CNT should be fully characterised reporting their length, purity, metal content and carbon 
soot. However, the research in this field is not conclusive for two reasons: 1) the absence of 
detailed  data about the characterization of the nanomaterials confuses the interpretation of 
toxicity data; 2) the reaction that CNTs have with certain reagents in the in vitro cell viability 
studies invalidates the results of these assays.. Wörle-Knirsch et al.  demonstrates 
interferences of carbon nanotubes with the MTT proliferation assay (Wörle-Knirsch et al., 
2006). For this reason, the use of different and independent assays to study toxicological 
effects of nanoparticles has been proposed and generally accepted. In order to define valid 
guidelines for toxicological studies on nanomaterials, the EU has recently established the 
Nano-safety Cluster – a network of researchers and toxicologists. They will consider the 
somewhat conflicting results and develop appropriate guidelines. In addition, there is an 
urgent need for the definition of ‘medical grade’ CNT in terms of length, purity and metal 
content. 
2.2 CNTs properties and their biomedical applications: The future of nanomedicine 
In the last ten years, several groups have shown that SWCNTs and MWCNTs can be used as 
excellent intracellular transporters to deliver therapeutic and diagnostic small molecules 
and macromolecules to cells. Different uptake mechanisms (phagocytosis, diffusion and 
endocytosis) have been reported in the literature. Some physico-chemical characteristics of 
the carbon nanotubes (e.g., the nanotube dispersion, the formation of supramolecular 
complexes, and the nanotube length) drive the uptake pathway (Raffa et al., 2010). Both 
SWCNTs and MWCNTs can be internalized by a variety of cell types and thus used to 
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deliver therapeutic and diagnostic molecules. Conjugation of CNTs with different molecules 
can be used for new vaccine production, novel therapies against retrovirus infection and 
tumor cell proliferation. Pantarotto et al reported that VP-1 protein of the foot-and-mouth 
disease virus (FMDV) covalently linked to SWCNT induced a specific anti-body response in 
vivo without any cross reactivity (Pantarotto et al., 2003). Liu et al transfected human T cells 
and peripheral blood mononuclear cells with siRNA molecules conjugated to CNTs to 
abrogate the expression of cell-surface receptors CD4 and co-receptors CXCR4 necessary for 
HIV entry and T cells infection (Liu et al., 2007). Additionally McDevitt et al constructed a 
specific CNT conjugated antibody to target the CD20 epitope on Human Burkitt lymphoma 
cells and simultaneously deliver a radionuclide (McDevitt et al 2007). The physical and 
chemical properties of MWCNTs (e.g., high strength, electrical conductivity, flexibility, 
functionalization with biomolecules) make them attractive as nano-vectors for enhanced cell 
and tissue growth on scaffolds in vitro (Balani et al., 2007) and for the development of 
complex neural prosthetic implants (Khabashesku et al 2005). 
CNTs also possess intriguing magnetic properties which derive from the metal catalyst 
impurities entrapped at the CNT extremities during their manufacture, these magnetic 
fields will interact with external magnetic fields. This property has been utilised by Cai et al. 
to develop a physical technique for in-vitro and ex-vivo gene transfer known as ‘nanotube 
spearing’, capable of effective cell transfection with plasmid DNA (Cai et al., 2005). 
Similarly, we have recently demonstrated that MWCNTs are able to interact with cells and, 
when exposed to a magnetic field, induce their migration towards the magnetic source 
(Vittorio et al 2010). This control of cell movement has important medical applications both 
in cell therapy for regeneration, cell transplantation and in cancer therapy (anti-metastasis). 
Moreover, we recently have demonstrated that MWCNTs with low metal impurities (2.57 % 
iron) can be used as MRI (magnetic resonance imaging) contrast agents even at 
concentrations of tens of μg/ml, as the MWCNTs have a significant effect on the observed 
1H transverse (1/T2) relaxation rate of water. Consequently, cells labelled with MWCNTs 
exhibit a reduced image intensity in T2-weighted MR images compared to cells without 
internalized MWCNTs. The 3D MRI cellular study suggests that it should be possible to 
track stem cells injected in vivo by labeling cells with these low Fe MWCNTs. It is possible 
that MRI could be used in the studies of biodistribution and the fate of carbon nanotubes in 
vivo (Vittorio et al 2011). Another important property of CNTs is their strong absorbance of 
near infra red (NIR) light  and subsequent release of this heat that can be utilised in the 
destruction of cells – nanohyperthermic ablation of tumours.  Shi Kam and colleagues 
achieved selective cancer cell destruction in vitro by using folate functionalized nanotubes 
heating and continuous NIR radiation (Shi Kam et al 2005 a). Additionally CNTs acquire 
and release heat on application of radio-frequency waves (58). Gannon et al. induced 
efficient heating of aqueous suspensions of SWNTs by applying RF waves. In particular they 
produced a selective and SWNT concentration dependent thermal destruction in vitro of 
human cancer cells that contained internalized SWNTs. Moreover they observed that 
intratumoral in vivo injection of SWNTs in the liver followed by immediate exposure to RF 
waves induced necrosis in the tumor mass with no apparent adverse effects on the healthy 
tissues (Gannon et al., 2007). A recent discovery (and patented by the NINIVE consortium) 
is the ability of CNTs to act as a dipole antenna and acquire a charge on exposure to 
electromagnetic radiation in the microwave range. This is the basis of an exciting new 
technology for remote wireless low voltage electro-chemotherapy and gene transfection and 
novel forms of electro-stimulation therapies for neurodegenerative disease (advanced 
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Parkinson’s disease unresponsive to medication), electrostimulation for skeletal and visceral 
muscle palsies and for cardiac arrhythmias. 
Several groups have investigated the potential of using nanoparticles in neurological 
applications. As carbon nanotubes/fibers have excellent electrical conductivity, strong 
mechanical properties and similar nano-scale dimensions to neurites, researcher have been 
explored their ability to guide axonal regeneration and to improve neural activity by acting 
as biomimetic scaffolds at sites of nerve injury. Mattson et al were the first group to 
demonstrate neurons grow on MWCNTs (Mattson et al., 2000). Moreover they reported an 
increase of over 200% in total neurite length and approximately 300% increase in the 
number of branches and neurites on MWCNTs coated with 4-hydroxynonenal compared to 
uncoated MWCNTs. Hu et al reported that positively charged MWCNTs significantly 
increased the number of growth cones and neurite branches compared to negatively 
charged MWCNTs (Hu et al., 2004). Gheith et al investigated the biocompatibility of a free-
standing positively charged single wall carbon nanotubes (SWCNT)/polymer thin-film 
membrane prepared by layer-by-layer assembly (Gheith et al., 2005). They observed a 94-
98% viability of neurons on the SWCNT/polymer films after 10 days of incubation and this 
induced neuronal cell differentiation, guided neuron extension and directed more elaborate 
branches than controls. Moreover, Lovat et al demonstrated that purified MWCNTs have 
the potential to boost electrical signal transfer of neuronal networks (Lovat et al., 2005). 
Recently Cellot et al  investigated the nature of CNT-neuron interactions and proposes a 
mechanism in which carbon nanotubes (CNTs) can boost neuronal activity by providing a 
shortcut for electrical coupling between somatic and dendritic neuronal compartments 
(Cellot et al., 2009). 
 
 
Fig. 1. CNT properties and their application in the biomedical field (Ciofani, G., Raffa, V., 
2009). 
2.3 Bio-medical imaging of CNTs 
One of the goals of nano-medicinal research is to produce bespoke multifunctional “nano-
devices” that can act as diagnostic devices, tissue-specific drug delivery systems or vehicles 
for gene therapy, ideally combining this with multimodal imaging capabilities (Hong et al., 
2009; Kostarelos et al,. 2009; Lui et al., 2009; Lu et al., 2009; Liu et al., 2010). Carbon 
nanotubes have many properties that make them particularly useful as biomedical devices 
(Hong et al., 2009; Kostarelos et al,. 2009; Lui et al., 2009; Lu et al., 2009; Liu et al., 2010). 
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Their microscopic morphology confers them with unique electrical, thermal, optical and 
magnetic properties. Coating the surface of CNT improves their solubility and their ‘needle-
like’ shape allows internalized by cells. By functionalizing the surface with biological active 
compounds, it is possible to use CNTs as ‘nano-vehicles’ delivering compounds into cells 
such as small molecule drugs, proteins, vaccines or in the case of gene therapy delivering 
siRNA. Thus CNTs have proved to be very effective carriers for gene delivery, with the 
advantage of avoiding the viral vectors used by other methods (Kostarelos et al., 2009). In 
addition, there are a number of CNTs strategies being developed to target CNTs to a region 
of interest, either by exploiting their magnetic properties or attaching targeting-ligands, such 
as antibodies or peptides, to their surface. With the exciting research published in this area, 
one should not forget that this technology is still in a developmental stage. Much work is 
still required in for example testing: (i) the effectiveness of CNT atfor targeting disease 
tissues; (ii) the stability efficacy of using CNTs to carry drugs to a region of interest and the 
profile of drug release; (iii) the precise mechanism of cell internalization as well as , and 
observing the sub-cellular compartments in which the CNTs accumulate; and also (iv) 
efficiency of using CNT as a heating methods for hyperthermia treatments. Undoubtedly 
there is still a lot to be done assessing the efficacy of the different CNT therapies as well as 
understanding the safety issues associated with CNTs. 
Bio-medical imaging has a vital role to play in testing both the efficacy of these new 
therapies and investigating their biodistribution. To date, the majority of imaging of CNTs 
has involved optical methods, such as fluorescence and bioluminescence microscopy (Hang 
et al., 2009). Optical microscopy has high spatial resolution, however it requires optically 
transparent samples. This is less of an issue in near-infrared photoluminescence imaging, 
Raman imaging, or photo acoustic tomography. THowever, there is a reduction in spatial 
resolution and sensitivity with these methods, and they still have tissue depth limitations. 
Attaching radionuclide labels onto CNTs allows three dimensional (3D) whole body,  in 
vivo molecular imaging such aseg position emission tomography (PET) and single photon 
emission computed tomography (SPECT). These techniques have high sensitivity, moderate 
resolution and have the advantage of being well established medical techniques, but they do 
involve ionising radiation. 
Magnetic resonance imaging (MRI) is an extremely versatile imaging modality, and 
particularly suitable for testing novel medical therapies as it is available as pre-clinical and 
clinical platforms, allowing a seamless transition from the laboratory into the clinic. MRI 
produces high resolution 3D images, non-invasively, from within optically opaque samples. 
The MRI signal originates from protons in water and lipid, and as a result the images 
contain impressive anatomical and pathological information. Furthermore, magnetic 
resonance (MR) can be used to interrogate tissue morphology, physiology, function, 
vascularity and metabolism. The versatility of MRI originates from the fact that signal 
intensity is dependent upon a number of physical parameters including the density of 
protons in the liquid state, 1H longitudinal (T1) and transverse (T2) relaxation times, and 
mass transport processes such as diffusion or flow (Modo et al 2007). In a simple 90o-180o-
acquire spin echo imaging sequence, the intensity of the MR magnetisation (Mt) observed in 
the spin echo can be expressed as: 
 
 Mt   =   Mo  .  exp (-TE/T2)  .  [1 - exp(-TR/T1)]  (1) 
if diffusion and flow are negligible, and when Mo is magnetisation at time zero, TE is echo 
time between excitation and detection of magnetisation, and TR is repetition time between 
successive imaging pulse sequences.  
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A limitation of MRI is that it is an inherently insensitive technique; this is due to its quantum 
physics and the Boltzmann’s distribution in particular. Its low sensitivity and low signal-to-
noise ratios are the reason most MR images map the location of water and lipids, as these 
molecules are found in high concentrations. It is also the reason that the intrinsic MRI spatial 
resolution is rarely below the order of 10’s of microns. Consequently, that it is not possible 
to detect a MRI signal directly from solid CNTs with low proton concentrations. Second, 
even if CNTs did produce a MRI detectable signal, they are so small that it would not be 
possible to see the shape of an an individual nanoparticle in an MRI image due to 
insufficient spatial resolution. However it is possible to use MRI to observe the location of 
CNTs indirectly, because magnetic CNTs can act asare MRI contrast agents and this can 
modify the appearance of an image. There are two classes of MRI contrast agents (CAs): T1 
CAs reduces the 1H T1 relaxation times of the water molecules in their vicinity, whilst T2 
CAs reduces 1H T2 relaxation times. T1 MRI CAs produces hyper-intensity in T1-weighted 
images thus appears white. They typically contain lanthanide ions; gadolinium is the most 
potent in this class with seven unpaired f-electrons. There are several Gd-chelated contrast 
agents with FDA approval including Omniscan, Multihance and Magnevist. T2 MRI 
contrast agents produce hypo-intensity in T2-weighted images thus appears black; this can 
be difficult to interpret if there are other black features in the image. Super-paramagnetic 
iron oxide nanoparticles are particularly potent T2 MRI CAs and formulations such as 
Feridex and Resovist have FDA approval for clinical use. The main purpose of contrast 
agents in the clinic is to improve disease detection and increase diagnostic confidence. 
The effectiveness of MRI contrast agents are evaluated by determining their longitudinal or 
transverse relaxivity, r1 or r2 respectively. Relaxivity is defined as the change in the 
relaxation rate of water protons per molar concentration of the contrast agent with units of 
s-1mM-1 and is expressed as: 
 ri [CA] = 1/Ti - 1/Tio (2) 
where ri is relaxivity; i=1 or 2; [CA] is the concentration of contrast agent; 1/Ti  is the 
longitudinal or transverse relaxation rate in the presence of contrast agent [CA]; and 1/Tio 
is the relaxation rate of the medium in the absence of contrast agent. To assist comparison of 
MRI data from different laboratories, it would be useful if new CNTs were tested against a 
set of ‘standard’standardized conditions such as using 1% agarose gels as a phantom and 
also using similar cell types. 
Choi et al attached superparamagnetic iron oxide nanoparticles onto SWCNTs to 
demonstrate the potential of CNTs as T2 MRI contrast agent. They imaged murine 
machrophage cells that had been incubated with these CNTs. The image contrast is 
generated by localised magnetic inhomogeneities induced by the magnetic CNTs, which 
reduces the T2 relaxation time of nearby water protons. Mesenchymal stem cells containing 
MWCNTs produced regions of hypo-intensity compared to untreated cells in T2-weighted 
RARE images (Vittorio et al. 2011) (Figure). Ananta et al measured the r2 relaxivity of three 
different types of SWCNTs. Interestingly, the r2 of pristine, low Fe content CNTs was twice 
as large as the relaxivity of raw, unpurified SWCNT; even though pristine SWCNT had 
three times less iron. Similarly, the relaxivity r2 of MWCNT with low iron content (2.57%) 
measured by Vittorio et al was 564 ± 41 s-1mM-1, (Vittorio et al. 2011), which was over three 
times higher than the relaxivity of commercial contrast agent Feridex measured under 
similar conditions (Chen et al. 2010). They attributed the relaxivity r2 to the presence of iron 
oxide impurities in the CNTs, which originate from the fabrication process, and to the 
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carbon MWCNT structure itself. Although the equation shown in Eq 2 is conventionally 
used to determine  relaxivity, in this situation to measure relaxivity relative to iron 
concentration alone is slightly misrepresentative. A study using magnetic iron oxide 
nanoworms neatly demonstrated that the r2 relaxivity was dependent on the intrinsic shape 
of the nanoparticles as well as to the presence of iron oxide impurities (Park et al., 2008). 
These results suggest that these nanoparticles are members of a new class of T2 relaxation 
agents where shape of the particle also contributes to relaxivity r2, this warrants further 
investigations. 
CNT T1 contrast agents have been produced by loading Gd3+ ions onto carbon nanotubes;. 
Sitharaman et al used ultra-short SWCNTs (Sitharaman et al., 2005), whilst Richard et al 
used MWCNTs (Richard et al., 2008). Superparamagnetic ultra-short single walled carbon 
nanotubes called ‘gadonanotubes’ have been produced (Sitharaman et al., 2010) with r1 and 
r2 relaxivity of 170 s-1mM-1 and 578 s-1mM-1 respectively. They are substantially more 
potent than the paramagnetic Gd chelates currently in clinical use. These contrast agents 
have the advantage that they can be used as either T1 positive CAs or T2 negative CAs. An 
in vivo study with rats using gadonanotubes generated negative hypo-intensity (Sitharaman 
et al., 2010). There are investigations into using these gadonanotubes as pH-probes since the 
T1 relaxation is sensitive to pH (Hartman et al., 2008). 
In vivo MRI has been utilised in detecting the bio-distribution and potential impact of CNTs 
and potential impact. CNTs are extremely stable and not easily bio-degraded and v. Very 
little is known of about how their long term they behaviour in vivo or their pharmacological 
profile. Faraj et al have used MRI to evaluated the bio-distribution of SWCNT in animals. A 
Their longitudinal, time course, in vivo MRI study observed the accumulation of carbon 
nanotubes in the spleen and liver of rats (Al Faraj et al., 2011) after intravenous injection, 
although no acute toxicological effect on the liver’s metabolic profile was observed. They 
also assessed the effects on the lungs of rats after inhaling SWCNTs using hyperpolarized  
3-He MRI (Al Faraj et al., 2009). The results from a 3 month follow-up study showed that 
granulomatous and inflammatory reactions were produced over time in a dose dependent 
manner (Al Faraj et al., 2010). 
In summary, the objective of the majority of MRI studies involving CNTs, to-date, have been 
evaluating the potential of CNTs as MRI contrast agents. The development of these bio-
nanomaterials is still in its early stage,P and consequently the fabrication, functionalisation 
and characterisation of novel CNTs is an important and fruitful area of research. Producing 
CNTs that are potent and stable MRI contrast agents is particularly essential when using this 
technique to track their movement in vivo the behaviour of CNTs in vivo. Obvious 
applications of this would be the tracking of stem cells and guiding their delivery. MRI also 
has a crucial role to play in assessing the behaviour of CNTs in vivo. Multinuclear MRI 
studies have been published following CNTs bio-distribution in animal models after 
intravenous injection and inhalation. The non-invasive nature of MRI makes it particularly 
suitable for such longitudinal time course, follow-up studies. However, it is our belief that 
the most important role of MRI in carbon nanotubes research will be evaluating the 
effectiveness of the various bio-medical applications and therapies associated with CNTs 
both in animal models and in the clinic. In hospitals, MRI is a work-horse imaging modality 
for the diagnosis of a broad range of diseases. It contributes to almost every aspect of 
disease management from diagnosis and staging a disease, to selecting and assessing 
therapies, and in follow-up and to detecting recurrence. It is theits ability of MRI to produce 
high resolution images with excellent anatomical and pathological contrast in animal 
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models of diseases as well as in the clinic, which will be needed when evaluating these new 
nanomaterials in targeted chemotherapy, focussed electrotherapy and gene therapy etc. 
 
 
Fig. 2. MWCNTs MRI study of mesenchymal stem cells (MSCs). Three vials were embedded 
in container of 1 % agarose: vial 1 (test) contains 97% MWCNTs in MSCs treated with 
surfactants held in agarose gels (cnt); vial 2 (control i) contains MSCs treated with 
surfactants held in agarose gels (pf), and vial 3 (control ii) contains MSCs cells held in 
agarose gels (c). (A) Photo of the dorsal view of the sample; (B) T2-weighted RARE-4 axial 
image of sample from the 128 by 128 by 128 RARE-4 (TR/TE=250/40 ms) data set; (C) 3D 
surface reconstruction of the sample from the same MRI data set as (B). MRI measurements 
were completed at 7.1 T, at 19oC, with field of view is 30 mm, and voxel spatial resolution of 
0.234 mm/pixel. (Vittorio et al., 2011 b) 
2.4 Magnetic properties of MWCNTs: Application for cell displacement in vitro 
The magnetic properties of MWCNTs can be exploited for many biomedical applications. 
An interesting application is represented by the possibility of labelling the cells with the 
magnetic nanoparticels and guide their localization by an external magnetic field. It is 
easy to image the exploitation of this methodology to move and collect metastatic cells, or 
to guide the cell transpalatation towards the target organ.  We recently used the same 
approach to guide and improve the nerve regeneration after the axon treatment with 
magnetic nanoparticles (www.marvene-project.org). The magnetic interactions of 
MWCNTs can be attributed to the metal particles encapsulated in the graphene sheet 
(Zhang et al., 2001; Glenis et al., 2004). After dispersion treatment, the tubes become water 
dispersible and as a result are shorter in length. These effects are propitious for the 
interaction between cells and CNTs: the reduced length and the reduced degree of 
agglomeration should limit toxicity response and at the same time could favour passive 
endocytosis (Wick et al., 2007).  We have experience in the study of interactions between 
nanomaterials and different cell lines. We spent much efforts in finding the best 
conditions to label cells with MWCNTs and to move them by magnetic field without 
compromising their physiological conditions.  
Under the effect of a permanent dipole magnet, cells have been seeded for three days with 
the CNT-modified medium: a progressive displacement of cells toward the more intensive 
magnetic fields was visible in the dishes where the CNTs have been added in culture, while 
in the control dishes (without CNTs) there was negligible translations of cells during the 
same period (Pensabene et al.,2008). Our results suggest that cell displacement occurs 
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during cell duplications. However, the displacement mechanism is still not clear, but the 
present result is a starting point to further investigation of the interaction between CNTs 
and cells and the controlled displacement of cells for selective cancer therapy. Concerning 
these issues, there are currently contrasting opinions and the mechanisms of interaction are 
still not clear. Two mechanisms can be supposed: the uptaking of the tubes (by endocytosis 
or pinocytosis) or their attachment to the cell membrane (Monch et al., 2005). The evidence 
of Figure 3 leads us to affirm that the binding of MWCNTs to cells is strong and the CNTs 
are able to drag along the cells, following the traction force generated by the permanent 
magnet. This effect could be used also to study how a mechanical stimulation of cells by 
CNTs can influence the cell activity (Cartmell et al., 2002). 
 
 
Fig. 3. Neuroblastoma cells displacement after three days in culture with MWNTs-modified 
medium. Control sample not showed (with Nikon TE2000U inverted optical microscope, 
magnifications 20X). (Pensabene et al., 2008) 
We also studied the interaction of magnetic carbon nanotubes with PC12 cells which 
represent a valid in vitro model to study the effect of nanoparticles in neuronal cells and the 
effect on differentiation in neurons (Vittorio et al 2011c). We demonstrate that when PC12 
cells were cultured in a MWCNT-containing medium, the nanotubes interact with the cells 
without compromising the cell’s viability and their ability to differentiate into neurons 
following exposure to NGF. As a result of this interaction, CNTs in the presence of a 
magnetic field are able to translocate cells, in response to a permanent magnetic field. In 
contrast, no displacement was observed in control samples when cells were cultured with a 
CNT-free cell culture medium. These results confirm the ability of MWCNTs to shepherd 
PC-12 cells in response to the force generated by a permanent magnet. We believe that 
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recent advances in nanoscience and nanotechnology may provide new therapeutic options 
as alternative/supplemental therapies to established surgical repair techniques for the 
treatment of peripheral nerve injuries. We studied the interaction between neuronal cell line 
and  magnetic carbon nanotubes, because this is an essential step to investigate the 
exploitation of magnetic nanoparticles to enhance/accelerate nerve regeneration and to 
provide guidance for the regenerating axons. 
2.5 Magnetic properties of MWCNTs: Application for stem cell displacement in vitro 
and to drive the homing of mesenchymal stem cells after their transplantation in vivo 
Next, we decided to try to move stem cells after their incubation with MWCNTs. With the  
aim of finding the best protocol to guide the cell homing towards the target organs and 
improve  stem cell transplantation strategy. Many experts in stem cells transplatation report 
the lack of efficient technology to inject stem cells in vivo in target sites and avoiding their 
dispersion. 
The experimental data obtained in our study confirm that magnetic fields can be used to 
control the movement and location of MSCs cultured with carbon nanotubes (Vittorio et al., 
2011 a). The cell distribution in control cultures MSCs in the Petri dish was homogeneous (350-
400 cells/mm2), whereas the cell density was more heterogeneous in the test culture. 
Specifically, in the test culture the MSCs density ranged from 200 cells/ mm2 to 800 cells/mm2, 
correlating respectively with  distances from the magnetic pole of 9-14 mm and 5 mm (Figure 
4) . This cell streaming behaviour was closely related to the intensity of the flux density within 
the Petri dish which ranged from a very low value (<0.1 T) when the distance from the 
magnetic pole was >9 mm to about 0.5 T at a distance of 5 mm. Mathematically, an MSC 
interacting with CNTs is subjected to a translational force in the presence of a gradient field of: 
 χ
µ
= ⋅ ⋅ ⋅ ⋅
0
1
m rp
dB
F V B
dr
 (3) 
where µ0 is the magnetic permeability of free space, Xrp and V are respectively the magnetic 
susceptibility and the total volume of magnetic nanotubes attached to the cell. Eq. 3 is a usefull 
mathematical tool to design the manipulation of MSCs cultured with carbon nanotubes by a 
magnetic flux gradient. The migration dynamics of a single cell shows that the cell moves 
towards the magnetic source with a speed of approximating 30 µm/h. Cell proliferation assays 
were performed to identify if there was any adverse effect of the nanotubes and/or the 
magnetic field on the viability, proliferation and functionality of MSCs. The results showed 
that the PF127 surfactant marginally decreased the cell viability but the cell viability reduction 
was negligible with PF127-CNTs. This can be explained by the action of the surfactant which 
wraps the nanotubes surface and reduces the amount of free PF127 in the medium (Vittorio et 
al 2009). Additionally, the data on the cell growth assays showed that the MSCs doubling time 
was not significantly influenced by the presence of either the nanotubes or the magnetic field 
and no apoptotic cells were observed in any of the samples studied.  
The in vitro studies also confirmed that cells treated with CNTs for up to 5 days maintain their 
ability to differentiate under specific conditions just as well as the untreated cells. The lack of 
adverse effects on cell viability and proliferation by MWCNTs observed in the present study 
needs to be compared with the reported findings by Mooney et al. In this study, hMSCs were 
treated for 24 h with both COOH-functionalised SWCNTs and OH-functionalised MWCNTs, 
at various concentrations. The authors demonstrated that COOH-functionalised SWCNT, at 
www.intechopen.com
 Carbon Nanotubes – Growth and Applications 
 
 
200 
concentration up to 32 µg/ml, did not affect cell viability, proliferation, differentiation and 
metabolic activity; but at higher concentrations, SWCNTs exerted detrimental effects on the 
cells. In contrast, OH-functionalised MWCNTs were found toxic at all concentrations (Mooney 
et al., 2008). In the present study, the MWCNTs were not functionalised but simply dispersed 
in an anionic surfactant and used at concentration of 10 µg/ml. Finally, the staining of the actin 
filaments suggested clearly that the treatment with the nanotubes and the exposure to the 
magnetic field did not alter cell morphology. 
The results of the in vivo experiments provide a proof of concept that MSCs cultured with 
CNTs can be shepherded by means of an external magnetic source towards a specific organ; 
specifically, we demonstrated that the application of an external magnetic field alters the 
biodistribution of CNT-labelled MSCs after intravenous injection into rats, increasing the 
accumulation of cells into the target organ. This observation assumes importance in view of 
the widespread interest in MSC-based cell therapy for tissue engineering, regeneration/ repair 
of damaged organs and allogeneic transplantation. As MSCs also exhibit immuno-modulatory 
and anti-inflammatory effects they may play a role in the in vivo induction of tolerance.  It was 
observed that  MSCs reduce the incidence and severity of Graft-Versus-Host-Disease (GVHD) 
(Le Blanc et al., 2007), as well as prolong skin graft survival.  
The clinical applications of MSCs require the administration of cells by the intravenous 
route, but their subsequent dispersion in many tissue and organs (Allers et al., 2004) reduces 
the number of cells which colonize the intended target organ. There is therefore a need to 
increase targeted stem cell localization and homing to the diseased site. The approach 
proposed in this paper has the potential to achieve the objective of site-specific localization 
of the CNT-labelled MSCs, by reducing their colonisation of other sites with consequent 
adverse effects resulting from their proliferation and differentiation in ectopic sites. In the 
animal model studied we were able to achieve a 3-fold increment of MSC localization in the 
target organ (liver), and a corresponding decrease of MSC localization in the lung and 
kidney, which represent a natural filter for stem cells (Figure 5). In a recent work, Gao 
demonstrated that intravenous infusion of sodium nitroprusside, a vasodilator, 
administered prior to the cells infusion, reduced by 15% the number of cells present in the 
lungs and increased by 10% the cells in the liver (Gao et al., 2001). Based on this result we 
are currently  investigating the combined action of a vasodilator and the magnetic guidance 
to enhance the targeted homing of cells. Additionally, we are optimising the protocol of 
CNT-labelled MSC transplantation and we are designing a magnetic applicator device 
which would allow a more accurate and controlled configuration of the magnetic field 
gradient applied to the target site. Further improvements could be the design of the 
magnetic field by finite element modelling (FEM), the development of a wearable device 
and the use of electromagnets for switching the magnetic field. 
In summary, we have demonstrated that when mesenchymal stem cells are cultured in a 
CNT- containing medium, the nanotubes interact with the cells without compromising the 
cell’s viability, proliferation rate, cell phenotype and cytoskeletal conformation. Moreover 
we confirmed that magnetically labelled cells maintained the ability to differentiate in 
adipocytes and osteocytes. As result of the cells interaction with CNTs, the application of a 
magnetic field, enables shepherding of MSCs to the desired location in vitro. Moreover, in 
the experimental model used we were able to increase significantly the localization of 
mesenchymal stem cells within the liver, with a reduction of their migration to other organs. 
This paves the way for the development of a new methodology for shepherding cells in a 
target tissue/organ. The application of such technology would significantly improve both 
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the range and efficacy of therapies based on transplanted cells, included totipotent, 
pluripotent multipotent stem cells, reprogrammable adult cells, induced pluripotent stem 
cells (iPSC) and embryonic stem cells. Compared to the existing methodologies, CNT-
labelled MSCs maintain their magnetization for a period over 24 hours and up to 3 weeks. 
The long-time magnetization should allow for an efficient cell manipulation via magnetic 
fields and a reliable cell tracking via magnetic resonance imaging. The application of such 
technology could significantly improve  the range and efficacy of the current and future cell 
therapies. Our findings pave the way for the exploitation of the magnetic properties of 
biocompatible carbon nanotubes to localize the stem cells in a target organ, after their 
transplantation. A controlled and localized stem cell transplantation represent the future of 
regenerative medicine. 
 
 
Fig. 4. Imaging of MSCs shepherding: (A). MSC-CNT-cultures (a) MSC-control (b).  
Cultures 72 h after magnet placement. Images taken at different distances from the magnet 
pole (1, 2 and 3 correspond respectively to 5, 9 mm and 14 mm from the magnetic pole).  
Cell is stained with Syto 82 fluorescent dye. (B). MSC density for test and control cultures 
after 72 h from the magnet placement at different distances from the magnet pole. Assays 
performed in quadruple and results are the mean±S.E.M. (vertical bars)  
(Vittorio et al 2011 a) 
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Fig. 5. Histochemical analysis: (A) Mean and S.E.M. values of positive cells for Perls staining 
in each type of organ;(B) Liver’s section of control sample; (C) Liver’s section with Perls 
labelled mesenchymal stem cells with magnetic nanotubes  (Vittorio et al., 2011 a) 
2.6 Exploitation of magnetic CNTs in gene therapy 
The magnetic properties of CNTs derive from metal catalyst impurities entrapped at their 
extremities during their manufacture or from filling the nanotubes with tailored materials  in 
which the active content is encapsulated by a protecting carbon shell (Weissker et al., 2010).  
One medical application of ferromagnetic material is the so-called ”magnetic fluid 
hyperthermia” (MFH). MFH is based on a controled transfer of power to magnetic 
nanoparticles by an alternating magnetic field which results in local generation of heat. 
Depending on the equilibrium temperature of the tumour tissue, this heat may either 
destroy the tumor cells directly (thermoablation) or result in a synergic reinforcement of 
radiation efficacy (hyperthermia) (Latorre et al., 2009). Much of the current research 
focuses on iron oxide nanoparticles which have proven their feasibility in animal 
experiments (Johannsen et al., 2005; Matsuoka et al., 2004)] and are now under clinical 
trials (Johannsen et al., 2007). The protective carbon shell of the magnetic CNT may avoid 
the toxicity problem associated of iron oxidation.  Degradation of the filling materials is 
avoided and potential toxicity and adverse effects suppressed, so that CNT become 
effective carrier system on the nanometer scale. Magnetic studies on the feasibility of iron-
containing carbon nanotubes for magnetic hyperthermia have been shown (Krupskaya et 
al., 2009). The authors presented a detailed magnetic study of iron containing carbon 
nanotubes (Fe-CNT), and highlighted their potential for contactless magnetic heating in 
hyperthermia cancer treatment. DC magnetization studies showed a different magnetic 
response of Fe-CNT powder compared to Fe-CNT dispersed in aqueous solution. The 
ferromagnetic Fe-CNT in powder did not show any hysteresis when dispersed in a liquid. 
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Such magnetic behaviour implies the rotation of the magnetic moments following the 
magnetic field. The fact that in the frozen dispersion they observed a ferromagnetic-like 
hysteresis, clearly indicates that the rotation of the magnetic moments in liquid is 
associated with the motion of the whole nanotube, but not of the moments within each 
particle. AC susceptibility measurements showed an increase of the susceptibility of  
Fe-CNT in a liquid dispersion compared to the powder. Again, this can be explained by 
the motion of Fe-CNT in the AC magnetic field. AC inductive heating experiments 
showed a substantial temperature increase of Fe-CNT dispersions in AC magnetic fields, 
which was dependent on the magnetic field. In summary, these results showed the 
feasibility of Fe-containing CNT in magnetic hyperthermia. Another intriguing 
application of magnetic CNTs is the so-called magnetofection.  
Magnetic nanoparticle-based transfection methods are based on the principles developed in 
the late 1970s by Widder and others for magnetically targeted drug delivery. Transfection 
using  of magnetic microparticles was first demonstrated in 2000 by Cathryn Mah, Barry 
Byrne and others at the University of Florida, both in vitro with C12S cells and in vivo in 
mice using an adenoassociated virus (AAV) linked to magnetic microspheres via heparin 
(Ma et al., 2002). Since these initial studies, the efficiency of this technique has been 
demonstrated in a variety of cells (Dobson, 2006). The technique is based on the coupling of 
genetic material to magnetic nanoparticles. In the case of in vitro magnetic nanoparticle 
based transfection, the particle/DNA complex (normally in suspension) is introduced into 
the cell culture where the field gradient produced by rare earth magnets (or electromagnets) 
placed below the cell culture. They increase sedimentation of the complex and increase the 
speed of transfection. In vivo applications apply magnetic fields focused over the target site 
have the potential to not only enhance transfection but also target the therapeutic gene to a 
specific organ or site within the body. Generally, particles carrying the therapeutic gene are 
injected intravenously and strong, magnets gradients are applied to capture the particles as 
they flow through the blood-stream. Once captured by the field, the particles are held at the 
target, where they are taken up by the tissue. The therapeutic genes can be released either 
via enzymatic cleavage of the cross-linking molecules, charge interactions, or degradation of 
the polymer matrix. Alternatively, if the DNA is embedded within the matrix, such as with 
hydrogels, alternating fields may be applied to heat the particles and release the genes from 
the magnetic carrier. An application of magnetically-driven drug-carrying CNTs in cells was 
suggested (Cai et al., 2005).  
Cai et al have designed an alternative physical method of in vitro and ex vivo gene transfer, 
called nanotube ‘‘spearing’’: CNTs grown from plasma-enhanced chemical vapour 
deposition contain nickel particle catalysts entrapped into their tips, allowing them to 
respond to a magnetic field. The tubes were covalently functionalized with a DNA strain 
containing the sequence coding for the enhanced green fluorescent protein (pEGFP-c1). 
Dividing and non dividing cells like Bal17, B-lymphoma, ex vivo splenic B cells and primary 
neurons were grown on a substrate and incubated with magnetic pDNA/CNT. First a 
rotating magnetic field drives the nanotubes to mechanically spear the cells. In a subsequent 
step, a static magnetic field pulled the tubes into the cells. The spearing set-up and 
procedure are illustrated in Figure 6. The cells were efficiently transfected as confirmed by 
fluorescent microscopy measurements. They demonstrated that both spearing steps are 
necessary for efficient transduction. The efficiency was equal to viral approaches even for 
non-dividing cells, such as primary B cells and neurons which are generally more difficult to 
transfect. 
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Fig. 6. Two step procedure for nanotube spearing: a) a rotating magnetic field drives 
nanotubes to spear the cells on a substratum (surface) and b) a static field pulls nanotubes 
into the cells. (Cai et al.,2005). 
The same researchers investigated the compatibility of the nanospearing with primary  
ex vivo cultures of B lymphocytes (Cai et al., 2007). They reported that, by applying the 
original 2-step procedure of the nanospearing, they noted by phase contrast microscopy  
B-cell blasts and cellular aggregation, suggesting non-specific B-cell activation  
(i.e., increased cell size, activation of signal transduction pathways, increased protein and 
RNA content, normally associated with stimulation by extrinsic growth factors). They 
conducted a comprehensive characterization of the potential effects of exposing ex vivo 
primary B cells to CNTs with respect to cellular activation, survival, and signal transduction. 
The original multistep nanospearing protocol was modifield to a single step process (cells 
were speared by positioning the cover slips directly over a permanent magnet) and by using 
non-covalent DNA immobilization strategy. The results indicate that CNT-mediated 
nanospearing of primary B cells does not result in non-specific activation of naıve B 
lymphocytes but facilitate efficient delivery of nucleic acids into B cells (Figure 7).  
 
  
Fig. 7. CNT were covalently functionalised with poly(L-lysine) (PLL-CNT) and incubated 
with FITC-oligos in order to achieve FITC-oligo–PLL–CNTs. The pictures show the delivery 
of FITC-oligo–PLL–CNTs into B lymphocytes following nanospearing. Bal17 cells were 
speared with 0.4 fmol non-FITC-oligo–PLL–CNT complexes (Control A) or with 0.02, 0.1, or 
0.4 fmol FITC-oligo PLL–CNTs. More control results are shown as ‘Control B’ (FITC-oligo 
alone) and ‘Control C’ (FITC-oligo-PLL) with the corresponding reagent treatments to cell 
following the spearing  procedures (Cai et al., 2007). 
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Recently, Cai and colleagues showed that CNT–cell complexes form in the presence of a 
magnetic field (Cai et al., 2008). The complexes were analyzed by flow cytometry as a 
quantitative method for monitoring the physical interactions between CNTs and cells. They 
observed an increase in side scattering signals, where the amplitude was proportional to the 
amount of CNTs that are associated with cells. Even after the formation of CNT–cell 
complexes, cell viability was not significantly decreased. The association between CNTs and 
cells was strong enough to be used for manipulating the complexes and thereby conducting 
cell separation with magnetic force. 
2.7 Summary and concluding   
The emergence of CNTs in the biomedical field have raising great hopes. CNTs have been 
proposed as components for DNA and protein biosensors, ion channel blockers and as 
bioseparators and biocatalysts. Their use is becoming relevant in many fields such as 
neuroscience research and tissue engineering. CNTs have been developed as scaffolds for 
neuronal and ligamentous tissue growth for regenerative interventions of the central 
nervous system (e.g. brain, spinal cord) and orthopaedic sites They have also been used as 
new platforms to detect antibodies associated with human autoimmune diseases with high 
specificity. This findings pave the way to the development of CNT-based diagnostic devices 
for the discrimination and identification of different proteins from serum samples and in the 
fabrication of microarray devices for proteomic analyses. Plus CNTs covalently modified 
with DNA and PNA (peptide nucleic acid) have led to innovative systems for hybridization 
of complementary DNA strands allowing ultrasensitive DNA detection. Furthermore, CNTs 
have also emerged as a new efficient, alternative tool for transporting and translocating 
therapeutic molecules. The development of new and efficient drug delivery systems is of 
fundamental importance in improving the pharmacological profiles of many classes of 
therapeutic molecules. CNTs can be functionalised with bioactive peptides, proteins, nucleic 
acids and drugs, and used to deliver their cargos to cells and organs. 
With the prospect of gene therapy, cancer treatments, and innovative therapies, the science 
of nanomedicine has become an fast-growing field that has an incredible ability to bypass 
barriers previously thought unavoidable. The properties and characteristics of CNTs are still 
being explored and scientists have barely begun to mine the potential of these structures. 
CNTs have already proven to serve as safer and more effective alternatives to previous drug 
delivery methods. They can serve as nano-vehicles, carrying therapeutic drugs, vaccines, 
and nucleic acids deep into the cell to targets previously unreachable in response to static 
and dynamic energetic fields.  
Carbon nanotubes have the potential of revolutionizing bio-medical research. They 
frequently show superior performance over other nanoparti-cles. The advantage lies in their 
unique combination of electrical, magnetic, optical and chemical properties which can be 
exploited in the development of new classes of CNT-based drugs and therapy. 
In this chapter we showed the extraordinary physical properties of carbon nanotubes and 
how such properties can play an important role in their biomedical application. In particular 
we discussed to the magnetic properties of CNTs and considered how they can improve the 
imaging, the cell labelling, the guided homing of stem cell and the selected delivery of drug 
towards tumour cells.  
The magnetic properties of  nanotubes can be also exploited to study in vivo biodistribution 
by using magnetic resonance. Al Faraj and colleagues performed a non-invasive follow-up 
in vivo study to evaluate the biodistribution of CNTs and effect of nanotube deposition after 
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exposure (Al Faraj et al., 2009). They used both helium-3 and proton magnetic resonance 
(MRI) to evaluate the biodistribution and biological impact of raw single-wall CNTs  
(raw- SWNTs) and superpurified SWNTs (SP-SWNTs) in a rat model. Superpurified 
SWNTs, thanks to low content of metal residuals, represent the best samples in terms of 
biocompatibility, but it is not possible with only MRI to fully understand their biodistribution 
in vivo.  
In a series of other experiments, the effectiveness of cellular imaging as T1 and T2 contrast 
agent was investigated.  
Cai et al. have designed an alternative physical method of in vitro and ex vivo gene transfer, 
called nanotube ‘‘spearing’’. The tubes were functionalized with DNA plasmids immobilized 
onto the CNTs and subsequently speared into target cells via external magnetic fields.  
Moreover, Cai and colleagues showed that CNT–cell complexes are formed in the presence 
of a magnetic field (Cai et al., 2008). Even after the formation of CNT–cell complexes, cell 
viability was not significantly decreased. The association between CNTs and cells was 
strong enough to be used for manipulating the complexes and thereby con-ducting cell 
separation with magnetic force.  
We demonstrated that, by combining the magnetic response with the ability to interact with 
cells (Vittorio et al., 2011a), CNTs can also be used for cell manipulation. Our  data showed 
that cells treated with nanotubes with ˜3% iron content are able to internalize this 
nanoparticle and to move towards a magnetic source.  
In cancer therapy, there is potential to prevent cell migration in metastasis. For example, 
CNTs could be functionalized so they bind selectively to cancer cells, by applying external 
magnetic field in order to constrain cancer cell migration. In addition, cancer cells treated 
with CNTs could act as intracellular transporters of chemotherapies or as heater probes. 
Moreover magnetic fields could be used to control movement and location of MSCs cultured 
with carbon nanotubes to shepherd MSCs towards the magnetic source, increasing the 
accumulation of cells into the target organ (liver). Undoubtedly, MWCNTs hold a distinct 
potential for use as nano-devices to improve therapeutic protocols for transplantation and 
homing of stem cells in vivo. 
We believe Nanomedicine will revolutionize the future of medical approaches. 
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